Children undergoing treatment for cancer -chemotherapy (CT) and/or radiotherapy (RT) -are prone to several long-term endocrine complications, which can permanently affect bone tissue, leading to a serious decrease of bone mineral density (BMD). Growth Hormone Deficiency (GHD) According to national criteria back then, he wasn't eligible for somatropin treatment.
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Pubertal spurt wasn't properly achieved (GHD)
13 years-old -P3, G3, TV 15 mL; BA = 11 years. 17 years-old -P5, G5 e VT 25 mL; BA = 17 years. Normal thyroid ultrasounds. Our patient developed GHD secondary to radiotherapy. This contributed to impaired bone mass acquisition. Methotrexate and glucocorticoids' adverse effects on bone are usually reversible. Peak bone mass should already been reached when partial gonadal axis insufficiency was established. The benefits of somatropin therapy are evident in several studies. It's required a long period for them to be observed, because the activation of osteoclasts preceds osteoblasts . It's important to identify the risk of endocrine complications in order to treat these patients properly. 
DISCUSSION
